ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $139,150 | -14.7% | 30,250 | +19.8% | 0.04% | -7.7% |
| Q2 2023 | $163,115 | -9.7% | 25,250 | +5.4% | 0.04% | -15.2% |
| Q1 2023 | $180,696 | -25.6% | 23,965 | 0.0% | 0.05% | -32.4% |
| Q4 2022 | $242,765 | +11.8% | 23,965 | +9.1% | 0.07% | -2.9% |
| Q3 2022 | $217,234 | -2.6% | 21,965 | +4.8% | 0.07% | 0.0% |
| Q2 2022 | $223,000 | +35.2% | 20,965 | +23.6% | 0.07% | +62.8% |
| Q1 2022 | $165,000 | -1.8% | 16,965 | +44.8% | 0.04% | 0.0% |
| Q4 2021 | $168,000 | – | 11,715 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |